Data Foundry

Drug recalls 2020

Caduet — Class II drug recall D-0842-2020

Terminated recall by Pfizer Inc., reported 2020-02-19, distributed nationwide. Defective Container: products potentially could have been packaged in defective bottles, with a notched rim, t

Recall numberD-0842-2020
Product typeDrug
ClassificationClass II
StatusTerminated
Voluntary or mandatedVoluntary
Recalling firmPfizer Inc., New York, NY, United States
Recall initiated2020-02-05
Classified2020-02-13
Reported by FDA2020-02-19
Terminated2021-03-08
DistributedNationwide (US)
Quantity128 bottles
Reason classespackaging
NDC00069-2150, 00069-2150-30, 00069-2160, 00069-2160-30, 00069-2170, 00069-2170-30, 00069-2180, 00069-2180-30, 00069-2190, 00069-2190-30, 00069-2250, 00069-2250-30, 00069-2260, 00069-2260-30, 00069-2270, 00069-2270-30, 00069-6180, 00069-6180-30, 00069-6323, 00069-6323-30, 00069-6565, 00069-6565-30, 00069-6747, 00069-6747-30, 00069-7232 and 7 more
Lot numbersCY0963
Expiration dates2022-07

Product

Caduet (amlodipine besylate/atorvastatin calcium) Tablets, 10 mg/10 mg*, 30-count bottle, Rx only, Distributed by: Pfizer Labs, Division of Pfizer Inc. NY, NY 10017, Made in Germany, NDC 0069-2160-30.

Reason for recall

Defective Container: products potentially could have been packaged in defective bottles, with a notched rim, that could cause inadequate foil sealing resulting in lack of moisture protection.

Machine access

This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0842-2020. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.

Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.